Impact of adverse events on ventricular assist device outcomes

Aleksandar Adzic, Snehal R. Patel, Simon Maybaum

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Left ventricular assist devices have been proven to be superior to medical therapy for advanced heart failure patients awaiting heart transplantation and viable alternatives to transplantation for destination therapy patients. Improvements in the design of ventricular assist devices have been rewarded by a decrease in adverse events and an increase in survival. Despite significant progress, even the latest generation left ventricular assist devices are burdened by a significant long-term adverse events profile that will increasingly challenge physicians as patients survive longer on implantable mechanical circulatory support. In this review, we analyze the impact of long-term adverse events on clinical outcomes in the major trials of continuous flow left ventricular assist devices. We discuss several of the more pertinent and interesting adverse events, examine their potential causes, and explore their future implications.

Original languageEnglish (US)
Pages (from-to)89-100
Number of pages12
JournalCurrent Heart Failure Reports
Volume10
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Heart-Assist Devices
Heart Transplantation
Heart Failure
Transplantation
Physicians
Survival
Therapeutics

Keywords

  • Adverse events
  • Aortic insufficiency
  • Continuous-flow
  • Device malfunction
  • Gastrointestinal bleeding
  • Infection
  • Left ventricular assist device(s)
  • Pump thrombosis
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Emergency Medicine

Cite this

Impact of adverse events on ventricular assist device outcomes. / Adzic, Aleksandar; Patel, Snehal R.; Maybaum, Simon.

In: Current Heart Failure Reports, Vol. 10, No. 1, 2013, p. 89-100.

Research output: Contribution to journalArticle

Adzic, Aleksandar ; Patel, Snehal R. ; Maybaum, Simon. / Impact of adverse events on ventricular assist device outcomes. In: Current Heart Failure Reports. 2013 ; Vol. 10, No. 1. pp. 89-100.
@article{8d1292cc22694de9b4da340acc53fa17,
title = "Impact of adverse events on ventricular assist device outcomes",
abstract = "Left ventricular assist devices have been proven to be superior to medical therapy for advanced heart failure patients awaiting heart transplantation and viable alternatives to transplantation for destination therapy patients. Improvements in the design of ventricular assist devices have been rewarded by a decrease in adverse events and an increase in survival. Despite significant progress, even the latest generation left ventricular assist devices are burdened by a significant long-term adverse events profile that will increasingly challenge physicians as patients survive longer on implantable mechanical circulatory support. In this review, we analyze the impact of long-term adverse events on clinical outcomes in the major trials of continuous flow left ventricular assist devices. We discuss several of the more pertinent and interesting adverse events, examine their potential causes, and explore their future implications.",
keywords = "Adverse events, Aortic insufficiency, Continuous-flow, Device malfunction, Gastrointestinal bleeding, Infection, Left ventricular assist device(s), Pump thrombosis, Stroke",
author = "Aleksandar Adzic and Patel, {Snehal R.} and Simon Maybaum",
year = "2013",
doi = "10.1007/s11897-012-0127-3",
language = "English (US)",
volume = "10",
pages = "89--100",
journal = "Nature Methods",
issn = "1548-7091",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Impact of adverse events on ventricular assist device outcomes

AU - Adzic, Aleksandar

AU - Patel, Snehal R.

AU - Maybaum, Simon

PY - 2013

Y1 - 2013

N2 - Left ventricular assist devices have been proven to be superior to medical therapy for advanced heart failure patients awaiting heart transplantation and viable alternatives to transplantation for destination therapy patients. Improvements in the design of ventricular assist devices have been rewarded by a decrease in adverse events and an increase in survival. Despite significant progress, even the latest generation left ventricular assist devices are burdened by a significant long-term adverse events profile that will increasingly challenge physicians as patients survive longer on implantable mechanical circulatory support. In this review, we analyze the impact of long-term adverse events on clinical outcomes in the major trials of continuous flow left ventricular assist devices. We discuss several of the more pertinent and interesting adverse events, examine their potential causes, and explore their future implications.

AB - Left ventricular assist devices have been proven to be superior to medical therapy for advanced heart failure patients awaiting heart transplantation and viable alternatives to transplantation for destination therapy patients. Improvements in the design of ventricular assist devices have been rewarded by a decrease in adverse events and an increase in survival. Despite significant progress, even the latest generation left ventricular assist devices are burdened by a significant long-term adverse events profile that will increasingly challenge physicians as patients survive longer on implantable mechanical circulatory support. In this review, we analyze the impact of long-term adverse events on clinical outcomes in the major trials of continuous flow left ventricular assist devices. We discuss several of the more pertinent and interesting adverse events, examine their potential causes, and explore their future implications.

KW - Adverse events

KW - Aortic insufficiency

KW - Continuous-flow

KW - Device malfunction

KW - Gastrointestinal bleeding

KW - Infection

KW - Left ventricular assist device(s)

KW - Pump thrombosis

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84873710120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873710120&partnerID=8YFLogxK

U2 - 10.1007/s11897-012-0127-3

DO - 10.1007/s11897-012-0127-3

M3 - Article

VL - 10

SP - 89

EP - 100

JO - Nature Methods

JF - Nature Methods

SN - 1548-7091

IS - 1

ER -